Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Initiating oral fingolimod treatment in patients with multiple sclerosis.
Analyzing differences between patient and proxy on Patient Reported Outcomes in multiple sclerosis.
Magnetic resonance elastography reveals altered brain viscoelasticity in experimental autoimmune encephalomyelitis.
Requirement for interleukin-1 to drive brain inflammation reveals tissue-specific mechanisms of innate immunity.
Body mass index and waist circumference in persons aging with muscular dystrophy, multiple sclerosis, post-polio syndrome, and spinal cord injury.
Improvement of interferon-beta related skin reactions after diluent halving: first experience of five patients.
Simvastatin in Relapsing Remitting Multiple Sclerosis (RRMS) Patients Using Avonex Compared to Placebo (irmsrct)
Neuropathic Pain in Multiple Sclerosis Improved With Oral Famciclovir: A Case Report.
Rituximab combination therapy in relapsing multiple sclerosis.
Resistance training and vibration improve muscle strength and functional capacity in female patients with multiple sclerosis.
Switching therapy from natalizumab to fingolimod in relapsing-remitting multiple sclerosis: clinical and magnetic resonance imaging findings.
[Neurology at the border of centuries: achievements and prospects].
Copy number variation in pediatric multiple sclerosis.
Insight towards the conserved water mediated recognition of catalytic and structural Zn(+2) ions in human Matrix Metalloproteinase-8 enzyme: A study by MD-simulation methods.
Medical and Nonstroke Neurologic Causes of Acute, Continuous Vestibular Symptoms.
Intractable and highly active relapsing multiple sclerosis - role of alemtuzumab.
Preferred features of oral treatments and predictors of non-adherence: two web-based choice experiments in multiple sclerosis patients.
Randomized controlled trial of a behavioral intervention targeting symptoms and physical activity in multiple sclerosis.
Rapid and reversible responses to IVIG in autoimmune neuromuscular diseases suggest mechanisms of action involving competition with functionally important autoantibodies.
Electrodiagnostic criteria for Guillain-Barrè syndrome: A critical revision and the need for an update.
Erratum to: Genomic Binding Sites and Biological Effects of the Vitamin D-VDR Complex in Multiple Sclerosis.
Bipolar disorder and multiple sclerosis: a case series.
Experimental Autoimmune Encephalomyelitis in Mice.
Stem cell-based therapies for multiple sclerosis: recent advances in animal models and human clinical trials.
Cladribine: mode of action and implications for treatment of multiple sclerosis.
Pages
« first
‹ previous
…
321
322
323
324
325
326
327
328
329
…
next ›
last »